No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
INDIA – Indian pharma giant Dr. Reddy’s Laboratories has agreed to sell certain non-core brands of the company in the dermatology segments to Eris Lifesciences Limited in a deal worth…
Read More
INDIA – Dr. Reddy’s Laboratories has struck a deal to buy the generic prescription product portfolio of Mayne Pharma Group Limited in the United States for up to US$150 million.…
Read More
INDIA – Aster Pharmacy, the retail arm of Aster DM Healthcare, has officially opened a new ultra-modern outlet at Elamakkara in Kerala, marking its 250th retail pharmacy in India. With…
Read More
INDIA – Dr. Reddy’s Laboratories has secured the U.S. Food and Drug Administration (USFDA) approval for its eye drops for post-surgery care, Difluprednate Ophthalmic Emulsion 0.05%. Following the regulatory approval,…
Read More
INDIA – Dr. Reddy’s Laboratories has reached a key milestone on the path to commercialization of its rituximab biosimilar, DRL_RI, as the drug major successfully completed the full set of…
Read More
INDIA – Dr. Reddy’s Laboratories Ltd. has acquired the domestic sale rights for breast cancer drug PRIMCYV® from Pfizer Products India Pvt Ltd. The trademark rights acquisition will build on…
Read More
ISRAEL – Theranica, a prescribed digital therapeutics company in Israel, has signed a strategic licensing pact with Dr. Reddy’s Laboratories Ltd. for the exclusive marketing and distribution of Nerivio® that…
Read More
INDIA – Dr Reddy’s Laboratories has launched Bortezomib for injection, used to treat certain types of cancer in the US market. A proteasome inhibitor, Bortezomib for injection is indicated for…
Read More
INDIA – Dr. Reddy’s Laboratories announced that it has acquired a portfolio of branded and generic injectable products from US-based Eton Pharmaceuticals, Inc for US$50 million. Under the terms of…
Read More
INDIA – Dr Reddy’s subsidiary Aurigene Discovery Technologies and Olema Pharmaceuticals, Inc have inked a pact with US-based Olema Pharmaceuticals to discover and develop novel cancer therapies. “We continue to…
Read More